Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Microbes hijack prostate cancer therapy Androgens such as testosterone and dihydrotestosterone are essential for male reproduction and sexual function. Androgens can also influence the growth of prostate tumor cells, and androgen deprivation therapy (ADT) either by surgical means (castration) or pharmacological approaches (hormone suppression), is the cornerstone of current prostate cancer treatments. Pernigoni et al . found that when the body was deprived of androgens during ADT, the gut microbiome could produce androgens from androgen precursors (see the Perspective by McCulloch and Trinchieri). Gut commensal microbiota in ADT-treated patients or castrated mice produced androgens that were absorbed into the systemic circulation. These microbe-derived androgens appeared to favor the growth of prostate cancer and helped to facilitate development into a castration- or endocrine therapy–resistant state. —PNK
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“polychemotherapy and endocrine therapy (such as androgen deprivation) can modulate the alpha and beta diversities of the microbiota, which have been proposed to affect treatment-related adverse events27,28 as well as drug metabolism and efficacy29,30.”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [29]
In the citing paper
“Nonetheless, we identified that participants with metastatic prostate cancer also cluster in the same cancerassociated clade as those with melanoma. 54”
From Global genetic diversity of human gut microbiome species is related to geographic location and host health (2025) · cites this paper as [54]
In the citing paper
“The original study indicated that some bacteria could produce androgens, such as testosterone, which are associated with adverse cancer outcomes. 54”
From Global genetic diversity of human gut microbiome species is related to geographic location and host health (2025) · cites this paper as [54]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
McMurdie, P. J., & Holmes, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061217 · Cited by 21,322
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W.-M., Fiehn, O., Goodacre, R., Griffin, J. L., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0082-2 · Cited by 5,368
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing
Bokulich, N. A., Subramanian, S., Faith, J. J., Gevers, D., Gordon, J. I., Knight, R., Mills, D. A., & Caporaso, J. G. (2013) · Nature Methods · doi:10.1038/nmeth.2276 · Cited by 4,401
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888
Cited by
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Galeano Niño, J. L., Wu, H., LaCourse, K. D., Kempchinsky, A. G., Baryiames, A., Barber, B., Futran, N., Houlton, J., Sather, C., Sicinska, E., et al. (2022) · Nature · doi:10.1038/s41586-022-05435-0 · Cited by 887
Targeting the gut and tumor microbiota in cancer
Park, E. M., Chelvanambi, M., Bhutiani, N., Kroemer, G., Zitvogel, L., & Wargo, J. A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01779-2 · Cited by 496
Androgen receptor activity in T cells limits checkpoint blockade efficacy
Guan, X., Polesso, F., Wang, C., Sehrawat, A., Hawkins, R. M., Murray, S. E., Thomas, G. V., Caruso, B., Thompson, R. F., Wood, M. A., et al. (2022) · Nature · doi:10.1038/s41586-022-04522-6 · Cited by 391
Understanding and targeting resistance mechanisms in cancer
Lei, Z., Tian, Q., Teng, Q., Wurpel, J. N. D., Zeng, L., Pan, Y., & Chen, Z. (2023) · MedComm · doi:10.1002/mco2.265 · Cited by 347
Sex hormone signaling and regulation of immune function
Hoffmann, J. P., Liu, J. A., Seddu, K., & Klein, S. L. (2023) · Immunity · doi:10.1016/j.immuni.2023.10.008 · Cited by 344
Bacteria in cancer initiation, promotion and progression
El Tekle, G., & Garrett, W. S. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00594-2 · Cited by 343
Targeting the gut microbiota for cancer therapy
Fernandes, M. R., Aggarwal, P., Costa, R. G. F., Cole, A. M., & Trinchieri, G. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00513-x · Cited by 290
Zhong, W., Wu, K., Long, Z., Zhou, X., Zhong, C., Wang, S., Lai, H., Guo, Y., Lv, D., Lu, J., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01289-w · Cited by 223
The coming decade in precision oncology: six riddles
Wahida, A., Buschhorn, L., Fröhling, S., Jost, P. J., Schneeweiss, A., Lichter, P., & Kurzrock, R. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00529-3 · Cited by 205
Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target
Wang, K., Zhang, Z., Hang, J., Liu, J., Guo, F., Ding, Y., Li, M., Nie, Q., Lin, J., Zhuo, Y., et al. (2023) · Science · doi:10.1126/science.add5787 · Cited by 173
Recent findings in Akkermansia muciniphila-regulated metabolism and its role in intestinal diseases
Liu, M.-J., Yang, J.-Y., Yan, Z.-H., Hu, S., Li, J.-Q., Xu, Z.-X., & Jian, Y.-P. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.08.029 · Cited by 166
Gut microbiota shapes cancer immunotherapy responses
Lei, W., Zhou, K., Lei, Y., Li, Q., & Zhu, H. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00786-8 · Cited by 194
Li, D., Liu, R., Wang, M., Peng, R., Fu, S., Fu, A., Le, J., Yao, Q., Yuan, T., Chi, H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.01.001 · Cited by 182
Teng, H., Wang, Y., Sui, X., Fan, J., Li, S., Lei, X., Shi, C., Sun, W., Song, M., Wang, H., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2022.11.013 · Cited by 149
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 139
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., & Zitvogel, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00785-8 · Cited by 141
Bouyahya, A., Omari, N. E., Hachlafi, N. E., Jemli, M. E., Hakkour, M., Balahbib, A., Menyiy, N. E., Bakrim, S., Mrabti, H. N., Khouchlaa, A., et al. (2022) · Molecules · doi:10.3390/molecules27103286 · Cited by 130
The gut microbiome and cancer: from tumorigenesis to therapy
Nobels, A., van Marcke, C., Jordan, B. F., Hul, M. V., & Cani, P. D. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01287-w · Cited by 136
Emerging targetome and signalome landscape of gut microbial metabolites
Zheng, X., Cai, X., & Hao, H. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.011 · Cited by 101
Gut microbiome and prostate cancer
Fujita, K., Matsushita, M., Banno, E., Velasco, M. A. D., Hatano, K., Nonomura, N., & Uemura, H. (2022) · International Journal of Urology · doi:10.1111/iju.14894 · Cited by 115
Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment
Kuštrimović, N. Z., Bombelli, R., Baci, D., & Mortara, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021511 · Cited by 115
Sex hormones influence the intestinal microbiota composition in mice
Wu, Y., Peng, X., Li, X., Li, D., Tan, Z., & Yu, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.964847 · Cited by 97
Inamura, K., Hamada, T., Bullman, S., Ugai, T., Yachida, S., & Ogino, S. (2022) · Gut · doi:10.1136/gutjnl-2022-327209 · Cited by 100
Zhang, G., Wang, Q., Tao, W., Jiang, W., Elinav, E., Wang, Y., & Zhu, S. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00903-4 · Cited by 86
Terrisse, S., Goubet, A.-G., Ueda, K., Thomas, A. M., Quiniou, V., Thelemaque, C., Dunsmore, G., Clave, E., Gamat-Huber, M., Yonekura, S., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004191 · Cited by 80
Gut microbiota and microbial metabolites for osteoporosis
Zheng, X.-Q., Wang, D.-B., Jiang, Y., & Song, C. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2437247 · Cited by 97
Andreu-Sánchez, S., Blanco-Míguez, A., Wang, D., Golzato, D., Manghi, P., Heidrich, V., Fackelmann, G., Zhernakova, D. V., Kurilshikov, A., Valles-Colomer, M., et al. (2025) · Cell · doi:10.1016/j.cell.2025.04.014 · Cited by 81
Microbiota-derived bile acids antagonize the host androgen receptor and drive anti-tumor immunity
Jin, W., Xiao, L., Jeong, M., Han, S.-J., Zhang, W., Yano, H., Shi, H., Arifuzzaman, M., Lyu, M., Wang, D., et al. (2025) · Cell · doi:10.1016/j.cell.2025.02.029 · Cited by 102
Self-citationChen, L., Xu, Y.-X., Wang, Y., Ren, Y.-Y., Dong, X.-M., Wu, P., Xie, T., Zhang, Q., & Zhou, J. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02137-1 · Cited by 92
Gut microbiota supports male reproduction via nutrition, immunity, and signaling
Cai, H., Cao, X., Qin, D., Liu, Y., Liu, Y., Hua, J., & Peng, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.977574 · Cited by 84
Experimental in vitro, ex vivo and in vivo models in prostate cancer research
Sailer, V., Amsberg, G. V., Duensing, S. M., Kirfel, J., Lieb, V., Metzger, E., Offermann, A., Pantel, K., Schüle, R., Taubert, H. W., et al. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00677-z · Cited by 82
The potential role of the microbiota in prostate cancer pathogenesis and treatment
Pernigoni, N., Guo, C. W., Gallagher, L., Yuan, W., Colucci, M., Troiani, M., Liu, L., Maraccani, L., Guccini, I., Migliorini, D., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00795-2 · Cited by 77
Self-citationBrina, D., Ponzoni, A. A., Troiani, M., Calì, B., Pasquini, E., Attanasio, G., Mosole, S., Mirenda, M., D’Ambrosio, M., Colucci, M., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00594-z · Cited by 75
Self-citationThe clinical and biochemical significance of 11-oxygenated androgens in human health and disease
Storbeck, K.-H., & O’Reilly, M. W. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad047 · Cited by 63
Microbial endocrinology: the mechanisms by which the microbiota influences host sex steroids
Cotton, S., Clayton, C. A., & Tropini, C. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.03.010 · Cited by 62
Yin, Z., Liu, B., Feng, S., He, Y., Tang, C., Chen, P., Wang, X., & Wang, K. (2023) · Nutrients · doi:10.3390/nu15184086 · Cited by 64
The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
Fujita, K., Matsushita, M., Velasco, M. A. D., Hatano, K., Minami, T., Nonomura, N., & Uemura, H. (2023) · Cancers · doi:10.3390/cancers15051375 · Cited by 67
Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context
Liu, Y., Niu, L., Li, N., Wang, Y., Liu, M., Su, X., Bao, X., Yin, B., & Shen, S. (2023) · Advanced Science · doi:10.1002/advs.202205641 · Cited by 60
Bodywide ecological interventions on cancer
Kroemer, G., McQuade, J. L., Mérad, M., André, F., & Zitvogel, L. (2023) · Nature Medicine · doi:10.1038/s41591-022-02193-4 · Cited by 57
Zhao, F., An, R., Ma, Y., Yu, S., Gao, Y., Wang, Y., Yu, H., Xie, X., & Zhang, J. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70273 · Cited by 54
The oral cancer microbiome contains tumor space–specific and clinicopathology-specific bacteria
Zeng, B., Tan, J. H., Guo, G.-L., Li, Z., Yang, L., Lao, X., Wang, D., Ma, J., Zhang, S., Liao, G., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.942328 · Cited by 57
Circulating androgen regulation by androgen-catabolizing gut bacteria in male mouse gut
Hsiao, T., Chou, C.-H., Chen, Y., Wang, P., Brandon-Mong, G.-J., Lee, T., Wu, T.-Y., Li, P.-T., Li, C., Lai, Y.-L., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2183685 · Cited by 47
High‐fat diet promotes prostate cancer growth through histamine signaling
Matsushita, M., Fujita, K., Hatano, K., Hayashi, T., Kayama, H., Motooka, D., Hase, H., Yamamoto, A., Uemura, T., Yamamichi, G., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34028 · Cited by 54
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
Zha, C., Peng, Z., Huang, K., Tang, K., Wang, Q., Zhu, L. J., Che, B., Li, W., Xu, S., Huang, T., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1196217 · Cited by 51
Lachance, G., Robitaille, K., Laaraj, J., Gevariya, N., Varin, T. V., Feldiorean, A., Gaignier, F., Bourdeau‐Julien, I., Xu, H. W., Hallal, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45332-w · Cited by 62
Rastelli, D., Robinson, A., Lagomarsino, V. N., Matthews, L. T., Hassan, R., Perez, K., Dan, W., Yim, P. D., Mixer, M., Prochera, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150789 · Cited by 51
Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis
Matsushita, M., Fujita, K., Hatano, K., Velasco, M. A. D., Uemura, H., & Nonomura, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.852382 · Cited by 48
Role of the gut microbiota in tumorigenesis and treatment
Liu, Q., Yang, Y., Pan, M., Yang, F., Yu, Y., & Qian, Z. (2024) · Theranostics · doi:10.7150/thno.91700 · Cited by 47
Lactate as Key Metabolite in Prostate Cancer Progression: What Are the Clinical Implications?
Chetta, P., Sriram, R., & Zadra, G. (2023) · Cancers · doi:10.3390/cancers15133473 · Cited by 51
Zhu, X., Huang, X., Hu, M., Sun, R., Li, J., Wang, H., Pan, X., Ma, Y., Ning, L., Tong, T., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.03.002 · Cited by 43
Yang, J., Lu, X., Hao, J., Li, L., Ruan, Y.-T., An, X.-N., Huang, Q., Dong, X., & Gao, P. H. (2025) · Nature Communications · doi:10.1038/s41467-025-56494-6 · Cited by 59
The contemporary management of prostate cancer
Chakrabarti, D., Albertsen, P. C., Adkins, A., Kishan, A. U., Murthy, V., Parker, C. C., Pathmanathan, A. U., Reid, A. H. M., Sartor, O., van As, N. J., et al. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70020 · Cited by 81
Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer
Nguyen, T., Sridaran, D., Chouhan, S., Weimholt, C., Wilson, A., Luo, J. R., Li, T., Koomen, J. M., Fang, B., Putluri, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38887-7 · Cited by 41
Luo, X., Wang, K., & Jiang, C. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.04.020 · Cited by 45
Gut microbial metabolites in cancer therapy
Song, P., Peng, Z., & Guo, X. (2025) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.06.016 · Cited by 38
Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
Zhang, H., Yi, Z., Xing, Z., Sah, R. K., Hu, J., & Hu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113521 · Cited by 46
An expanded metabolic pathway for androgen production by commensal bacteria
Wang, T., Ahmad, S., Cruz-Lebrón, A., Ernst, S. E., Caicedo, K. Y. O., Jeong, Y., Binion, B., Mbuvi, P., Dutta, D., Fernández-Materán, F. V., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01979-9 · Cited by 49
Dietary fibre-adapted gut microbiome clears dietary fructose and reverses hepatic steatosis
Jung, S., Bae, H., Song, W., Chun, Y., Le, J., Alam, Y. H., Verlande, A., Chun, S. K., Kim, J., Kelly, M. E., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01356-0 · Cited by 43
Bidirectional relationships between the gut microbiome and sexual traits
del Castillo-Izquierdo, Á., Mayneris‐Perxachs, J., & Fernández‐Real, J. M. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00116.2022 · Cited by 36
Sepich‐Poore, G. D., Guccione, C., Laplane, L., Pradeu, T., Curtius, K., & Knight, R. (2022) · BioEssays · doi:10.1002/bies.202100252 · Cited by 33
“Genetic clonal evolution also fails to account for microbialmediated treatment efficacy or failure of (i) cyclophosphamide,[66,101] gemcitabine,[47] and platinum-based[67,102] chemotherapy; (ii) antiCTLA-4 and anti-PD-(L)1 ICB efficacy[12–14,96–100]; (iii) androgen deprivation therapy in prostate cancer[65]; and (iv)…”
BackgroundInfluentialCharacteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma
Chen, Y., Ma, J., Dong, Y., Yang, Z., Zhao, N., Liu, Q., Zhai, W., & Zheng, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.913718 · Cited by 43
Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome
Kumar, N. B., Hogue, S., Pow‐Sang, J. M., Poch, M. A., Manley, B. J., Li, R., Dhillon, J., Yu, A. C., & Byrd, D. A. (2022) · Cancers · doi:10.3390/cancers14163988 · Cited by 34
Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy
Terrisse, S. A., Zitvogel, L., & Kroemer, G. (2022) · Microbial Cell · doi:10.15698/mic2022.12.787 · Cited by 38
Emerging Relationship between the Gut Microbiome and Prostate Cancer
Matsushita, M., Fujita, K., Hatano, K., Velasco, M. A. D., Tsujimura, A., Uemura, H., & Nonomura, N. (2023) · The World Journal of Men s Health · doi:10.5534/wjmh.220202 · Cited by 37
The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions
Qasem, H., & El-Sayed, W. M. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01523-9 · Cited by 34
Estrogens and Androgens in Plants: The Last 20 Years of Studies
Janeczko, A. (2021) · Plants · doi:10.3390/plants10122783 · Cited by 36
Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer
Hou, Z., Huang, S., Mei, Z., Chen, L., Guo, J., Gao, Y., Zhuang, Q., Zhang, X., Tan, Q., Yang, T., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100561 · Cited by 40
Impact of intestinal dysbiosis on breast cancer metastasis and progression
Zhang, J., Xie, Q., Huo, X., Liu, Z., Da, M., Yuan, M., Zhao, Y. D., & Shen, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1037831 · Cited by 35
The role of the sex hormone-gut microbiome axis in tumor immunotherapy
Wang, L., Tang, L., Zhai, D., Song, M., Li, W., Xu, S., Jiang, S., Meng, H., Liang, J., Wang, Y., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185035 · Cited by 34
Microbiota as the unifying factor behind the hallmarks of cancer
Benešová, I., Křížová, Ľ., & Kverka, M. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05244-6 · Cited by 35
Engineering nanoplatforms of bacterial outer membrane vesicles to overcome cancer therapy resistance
Chai, Q., Li, D., Zhang, M., Gu, Y., Li, A., Wu, X., Liu, X., & Liu, J. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101277 · Cited by 36
Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
Kunika, Frey, N., & Rangrez, A. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087261 · Cited by 34
Brevi, A., Cogrossi, L. L., Lorenzoni, M., Mattorre, B., & Bellone, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845422 · Cited by 32
Self-citationExosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling
Wang, W., Kong, P., Feng, K., Liu, C., Gong, X., Sun, T., Duan, X., Sang, Y., Jiang, Y., Li, X., et al. (2023) · Cancer Science · doi:10.1111/cas.15948 · Cited by 28
Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities
Kim, S. J., Park, M., Choi, A., & Yoo, S. (2024) · Pharmaceuticals · doi:10.3390/ph17010112 · Cited by 35
Cancer invasion and anaerobic bacteria: new insights into mechanisms
Hurst, R., Brewer, D. S., Gihawi, A., Wain, J. R., & Cooper, C. S. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001817 · Cited by 29
Prostate cancer in transgender women: considerations for screening, diagnosis and management
Crowley, F., Mihalopoulos, M., Gaglani, S., Tewari, A. K., Tsao, C., Djordjević, M. L., Kyprianou, N., Purohit, R. S., & Lundon, D. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01989-y · Cited by 32
The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy
Qi, X., Liu, Y., Hussein, S., Choi, G., Kimchi, E. T., Staveley-O’Carroll, K. F., & Li, G. (2022) · Cells · doi:10.3390/cells11223684 · Cited by 30
Integration of androgen hormones in endometrial cancer biology
Gjorgoska, M., & Rižner, T. L. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.06.001 · Cited by 30
Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy
Zhou, P., Hu, Y., Wang, X., Shen, L., Liao, X., Zhu, Y., Yu, J., Zhao, F., Zhou, Y., Shen, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.877939 · Cited by 31
Targeting sex steroid biosynthesis for breast and prostate cancer therapy
POUTANEN, M. H., Thulin, M. H., & Härkönen, P. L. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00609-y · Cited by 32
Cushing Syndrome Is Associated With Gut Microbial Dysbiosis and Cortisol-Degrading Bacteria
Zhang, M., Shi, Z., Wu, C., Yang, F., Su, T., Jing, X., Shi, J., Ren, H., Jiang, L., Jiang, Y., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad766 · Cited by 29
Living therapeutics: Precision diagnosis and therapy with engineered bacteria
Xie, R., Fan, D., Cheng, X., Yin, Y., Li, H., Wegner, S. V., Chen, F., & Zeng, W. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123342 · Cited by 31
Hachem, S., Yehya, A., Masri, J. E., Mavingire, N., Johnson, J. R., Dwead, A. M., Kattour, N., Bouchi, Y., Kobeissy, F. H., Rais‐Bahrami, S., et al. (2024) · Biology · doi:10.3390/biology13100762 · Cited by 35
Butterflies in the gut: the interplay between intestinal microbiota and stress
Lai, T.-T., Liou, C.-W., Tsai, Y.-H., Lin, Y.-Y., & Wu, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00984-6 · Cited by 29
Understanding and overcoming resistance to immunotherapy in genitourinary cancers
Evans, S. T., Jani, Y. C., Jansen, C. S., Yıldırım, A., Kalemoglu, E., & Bilen, M. A. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2342599 · Cited by 26
Novel Therapeutic Strategies for Metastatic Prostate Cancer Care
Cimadamore, A., Boixareu, C., Sharp, A., Beltran, H., & Bono, J. S. D. (2025) · European Urology · doi:10.1016/j.eururo.2025.06.013 · Cited by 31
Rastelli, D., Robinson, A. F., Lagomarsino, V. N., Matthews, L., Hassan, R., Perez, K., Dan, W., Yim, P. D., Mixer, M., Prochera, A., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 24
Intratumor microbiota: a novel tumor component
Gong, Y., Huang, X., Wang, M., & Liang, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04576-7 · Cited by 28
New insights into gut microbiota–prostate cancer crosstalk
Laaraj, J., Lachance, G., Bergeron, A., Fradet, Y., Robitaille, K., & Fradet, V. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.03.015 · Cited by 27
Gut Bacteria Metabolize Natural and Synthetic Steroid Hormones via the Reductive OsrABC Pathway
Jacoby, C., Scorza, K., Ecker, L., Bernardino, P. N., Little, A. S., McMillin, M., Ramaswamy, R., Sundararajan, A., Sidebottom, A. M., Lin, H., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2025.09.014 · Cited by 29
Yan, Y., Wang, Z., Zhou, Y., Gao, Z., Ning, L., Zhao, Y., Xuan, B., Ma, Y., Tong, T., Huang, X., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101153 · Cited by 34
Zhou, C., Zhang, Y., Guo, S. J., Huang, Y., Qiao, X.-N., Wang, R., Zhao, L., Chang, D., Zhao, L.-M., Da, M., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1287995 · Cited by 31
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives
Li, D., Wu, R., Yu, Q., Tuo, Z., Wang, J., Yoo, K. H., Wei, W., Yang, Y., Ye, L., Guo, Y., et al. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.03 · Cited by 30
Wang, L., Lu, C., Wang, X., & Wu, D. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117829 · Cited by 27
The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone
Zi, C., Wang, D., Gao, Y., & He, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1104943 · Cited by 29
Microbiota and Resveratrol: How Are They Linked to Osteoporosis?
Meyer, C., Brockmueller, A., de Porras, V. R., & Shakibaei, M. (2024) · Cells · doi:10.3390/cells13131145 · Cited by 27
Advanced Bioinspired Multifunctional Platforms Focusing on Gut Microbiota Regulation
Li, M., Wang, L., Lin, D., Liu, Z., Wang, H., Yang, Y., Sun, C., Ye, J., & Liu, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c05013 · Cited by 28
Gut bacteria enable prostate cancer growth
McCulloch, J. A., & Trinchieri, G. (2021) · Science · doi:10.1126/science.abl7070 · Cited by 21
Impact of microbiota on breast cancer hormone therapy
Terrisse, S. A., Zitvogel, L., & Kroemer, G. (2023) · Cell Stress · doi:10.15698/cst2023.03.277 · Cited by 22
Metadata
- Authors
- Pernigoni, N., Zagato, E., Calcinotto, A., Troiani, M., Mestre, R. P., Calì, B., Attanasio, G., Troisi, J., Minini, M., Mosole, S., Revandkar, A., Pasquini, E., Elia, A. R., Bossi, D., Rinaldi, A., Rescigno, P., Flohr, P., Hunt, J., Neeb, A., Buroni, L., Guo, C., Welti, J., Ferrari, M., Grioni, M., Gauthier, J., Gharaibeh, R. Z., Palmisano, A., Lucchini, G. M., D’Antonio, E., Merler, S., Bolis, M., Grassi, F., Esposito, A., Bellone, M., Briganti, A., Rescigno, M., Theurillat, J.-P., Jobin, C., Gillessen, S., de Bono, J., & Alimonti, A.
- Affiliations
- Institute of Oncology Research (CH)
- Ente Ospedaliero Cantonale (CH)
- Theoreo Srl, Montecorvino Pugliano, 84090 Salerno, Italy.
- Candiolo Cancer Institute (IT)
- Royal Marsden NHS Foundation Trust (GB)
- IRCCS Ospedale San Raffaele (IT)
- University of Florida Health (US)
- Vita-Salute San Raffaele University (IT)
- University of Verona (IT)
- Mario Negri Institute for Pharmacological Research (IT)
- Institute for Research in Biomedicine (CH)
- IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy.
- Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
- University of Padua (IT)
- Corresponding author
- Pernigoni, Nicolò
- Zagato, Elena
- Calcinotto, Arianna
- Alimonti, Andrea
- ORCID
- Pernigoni, Nicolò
- Zagato, Elena
- Calcinotto, Arianna
- Mestre, Ricardo Pereira
- Calì, Bianca
- Troisi, Jacopo
- Minini, Mirko
- Mosole, Simone
- Pasquini, Emiliano
- Elia, Angela Rita
- Bossi, Daniela
- Rinaldi, Andrea
- Rescigno, Pasquale
- Flohr, Penny
- Neeb, Antje
- Buroni, Lorenzo
- Guo, Christina
- Welti, Jonathan
- Grioni, Matteo
- Gauthier, Josée
- Gharaibeh, Raad Z.
- Palmisano, Anna
- D’Antonio, Eugenia
- Merler, Sara
- Bolis, Marco
- Grassi, Fabio
- Esposito, Antonio
- Bellone, Matteo
- Briganti, Alberto
- Rescigno, Maria
- Theurillat, Jean-Philippe
- Jobin, Christian
- Gillessen, Silke
- de Bono, Johann
- Alimonti, Andrea
- Venue
- Science
- Published
- 2021-10-08
- Volume
- 374
- Issue
- 6564
- Pages
- 216-224
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3201967841
- Cited by
- 323
- References
- 55
- Citations by year
- 2026: 55 · 2025: 77 · 2024: 63 · 2023: 55 · 2022: 64 · 2021: 9
- FWCI
- 31.37
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health and Care Research (NF-SI-0617-10099)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- prostate cancer, gut microbiota, commensal bacteria, androgen production, endocrine therapy resistance, androgen deprivation therapy, castration, dihydrotestosterone, testosterone
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Host Microbial Interactions, Aged, Aged, 80 and over, Androgen Antagonists, Androgens, Animals, Anti-Bacterial Agents, Bacteria, Humans, Male, Mice, Inbred C57BL, Middle Aged, Neoplasms, Experimental, Symbiosis, Mice, SCID, Mice, Inbred NOD, Prevotella, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Prostatic Neoplasms, Castration-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.